How melanoma evades targeted therapies

Tuesday, November 6, 2018 - 13:40 in Health & Medicine

New research shows how metastatic melanoma becomes resistant to a common class of targeted therapy.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net